| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |